Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Petrelintide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zealand Pharma Unveils Metabolic Frontier 2030 Strategy
    Zealand Pharma Unveils Metabolic Frontier 2030 Strategy

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203618/0/en/Zealand-Pharma-outlines-Metabolic-Frontier-2030-strategy-to-become-a-generational-biotech-leader-in-obesity-and-metabolic-health.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    Ascletis Chooses ASC36, A Monthly Subcutaneous Amylin Agonist
    Ascletis Chooses ASC36, A Monthly Subcutaneous Amylin Agonist

    30 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ascletis-selects-a-best-in-class-once-monthly-subcutaneously-administered-amylin-receptor-agonist-asc36-for-clinical-development-302598384.html

    PR NEWSWIRE
    30 Oct 2025
    Share Share
    Zealand Pharma May Sell Future Obesity Drug Direct to Patients
    Zealand Pharma May Sell Future Obesity Drug Direct to Patients

    23 Sep 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/zealand-pharma-may-sell-future-obesity-drug-direct-patients-amid-market-shifts-2025-09-22/

    REUTERS
    23 Sep 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.